Showing results (11-20 of 157) with videos related to
Sort By:
Pageof 16
Clinical Pharmacology and Therapeutics|December 21, 2006
Drug interactions with lipid-lowering drugs: mechanisms and clinical relevancePertti J Neuvonen, Mikko Niemi, Janne T BackmanBritish Journal of Clinical Pharmacology|April 2, 2005
Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjectsJari J Lilja, Janne T Backman, Pertti J NeuvonenDrug Metabolism and Disposition: the Biological Fate of Chemicals|September 21, 2006
Rofecoxib is a potent, metabolism-dependent inhibitor of CYP1A2: implications for in vitro prediction of drug interactionsMarjo J Karjalainen, Pertti J Neuvonen, Janne T BackmanEuropean Journal of Clinical Pharmacology|March 1, 2015
Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosingSamuel Fanta, Mari Kinnunen, Janne T Backman, et al.European Journal of Clinical Pharmacology|July 10, 2007
Tolfenamic acid is a potent CYP1A2 inhibitor in vitro but does not interact in vivo: correction for protein binding is needed for data interpretationMarjo J Karjalainen, Pertti J Neuvonen, Janne T BackmanBasic & Clinical Pharmacology & Toxicology|June 30, 2018
In Vitro Screening of Six Protein Kinase Inhibitors for Time-Dependent Inhibition of CYP2C8 and CYP3A4: Possible Implications with regard to Drug-Drug InteractionsAnne M Filppula, Tiffany M Mustonen, Janne T BackmanBasic & Clinical Pharmacology & Toxicology|September 26, 2008
In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactionsMarjo J Karjalainen, Pertti J Neuvonen, Janne T BackmanBasic & Clinical Pharmacology & Toxicology|December 21, 2005
Effect of itraconazole on the pharmacokinetics of atenololJari J Lilja, Janne T Backman, Pertti J NeuvonenEuropean Journal of Clinical Pharmacology|January 17, 2008
Celecoxib is a CYP1A2 inhibitor in vitro but not in vivoMarjo J Karjalainen, Pertti J Neuvonen, Janne T BackmanDrug Metabolism and Disposition: the Biological Fate of Chemicals|April 10, 2014
In vitro assessment of time-dependent inhibitory effects on CYP2C8 and CYP3A activity by fourteen protein kinase inhibitorsAnne M Filppula, Pertti J Neuvonen, Janne T BackmanPageof 16